About Drug Repurposing
The Drug Repurposing journal aims to provide an interdisciplinary and cross-sectional overview of the various fields of research and applied sciences that work together to make successful drug repurposing projects a reality. High-throughput and high-content screening, in silico docking studies, pathway-based molecular pharmacology, bioinformatics, mining of peer-reviewed literature, patent documents, and side effect records, and design of drug repurposing trials are all part of this. We also welcome manuscripts that address strategic and ethical issues that are relevant in the broader context of drug repurposing, such as regulatory affairs, health technology assessment, and intellectual property. We especially welcome contributions that emphasize the specific integrative aspects of drug repurposing.
Drug Repurposing publishes high quality basic science, translational, and clinical research in the form of original research articles, comprehensive review articles, mini-reviews, rapid communications, brief reports, technology reports, hypothesis articles, perspectives, and letters to the editor. The Journal publishes under the Creative Commons Attribution 4.0 (CC BY) license to ensure broad dissemination and participation.
Official launch and editions
The official launch of the inaugural issue for the Drug Repurposing journal coincided with our latest RExPO24 conference in Munich back in July 2024. This first edition featured a robust collection of discussion articles, research papers and review articles, jointly portraying the breadth of the drug repurposing field. The goal is to catalyze progress, inspire collaboration and ultimately improve patient outcomes through the strategic repurposing of pharmaceuticals. Given the highly interdisciplinary nature of drug repurposing, multidisplinary is a cornerstone, and contributions from bioinformatics, cheminformatics, preclinical validation, clinical trials, ethics by design, freedom-to-operate, patenting strategies, business development, funding, regulatory, and reimbursement sectors are welcome.
Now, our Drug Repurposing journal is back with a second issue – read on for a sneak peek of everything that can be found inside and revisit past issues for key insights and collaborations.
Clinical efficacy landscaping in genetic obesity: A meta-analysis in Prader Willi syndrome (PWS)
Advancing Drug Discovery through Integrative Computational Models and AI Technologies
Looking for a Premier Publishing Portal for Drug Repurposing Research?
Created as a joint enterprise by REPO4EU and ScienceOpen, Drug Repurposing Central is the premier publishing portal for researchers specializing in drug repurposing, network medicine and precision healthcare. Our portal provides a comprehensive list of resources collating the latest research, and offers multiple publication channels, including preprints, journal articles, conference abstracts, reports, and books.
Researchers can actively participate in sharing and discussion within an open review environment, powered by ScienceOpen’s innovative discovery infrastructure. Developed under the Horizon Europe project, REPO4EU, which aspires to establish a European Platform for Drug Repurposing with global outreach, Drug Repurposing Central offers unparalleled access to publishing and reading resources at no cost. This portal is steadfast in its commitment to advancing Open Science, ensuring the utmost integrity of research outputs through consistent use of persistent identifiers and XML standards.